|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT01838005 |
|
Date of registration:
|
22/03/2013 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Conditional Cash Transfers to Increase Uptake of and Retention of PMTCT Services
|
|
Scientific title:
|
Conditional Cash Transfers to Increase Uptake of and Retention of PMTCT Services |
|
Date of first enrolment:
|
April 2013 |
|
Target sample size:
|
433 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT01838005 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Health Services Research. Masking: Single (Care Provider).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Congo
| | | | | | | |
|
Contacts
|
|
Name:
|
Marcel Yotebieng, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Ohio State University |
|
|
Name:
|
Emile W Okitolonda, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Kinshasa School of Public Health |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Newly diagnosed as HIV-positive
- Pregnant between 28 and 32 weeks of gestation (>27 and <32 completed weeks of
pregnancy)
- Intend to stay in Kinshasa through delivery and six weeks postpartum
- Able and willing to participate (provide informed consent)
Exclusion Criteria:
- Women will be excluded from the study if they are severely ill and require extended
hospitalization or need to be cared for at a referral hospital out of the PMTCT
network
Age minimum:
N/A
Age maximum:
N/A
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
HIV
|
|
Intervention(s)
|
|
Behavioral: Conditional cash transfer
|
|
Primary Outcome(s)
|
|
proportion of women who were adherent to all conditionalities and received the most effective ARV intervention they were eligible to receive and delivered at an affiliated maternity
[Time Frame: 6 weeks postpartum]
|
|
Secondary Outcome(s)
|
|
HIV-free survival at 18 month.
[Time Frame: 18 months porstpartum]
|
|
Mother to child transmission rate at six weeks and HIV-free survival.
[Time Frame: 6 weeks post partum]
|
|
Proportion of HIV-exposed infants who at their six week visit received extended Nevirapine (NVP) had a DNA PCR test
[Time Frame: 6 weeks Postpartum]
|
|
Secondary ID(s)
|
|
1R01HD075171-01
|
|
12-1676
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|